1.00
-0.01(-0.99%)
Currency In USD
Previous Close | 1.01 |
Open | 1.01 |
Day High | 1.06 |
Day Low | 1 |
52-Week High | 30.1 |
52-Week Low | 0.92 |
Volume | 168,745 |
Average Volume | 2.86M |
Market Cap | 4.37M |
PE | -0.02 |
EPS | -60.77 |
Moving Average 50 Days | 1.54 |
Moving Average 200 Days | 5.23 |
Change | -0.01 |
If you invested $1000 in Nuwellis, Inc. (NUWE) 10 years ago, it would be worth $0 as of December 22, 2024 at a share price of $1. Whereas If you bought $1000 worth of Nuwellis, Inc. (NUWE) shares 5 years ago, it would be worth $0.01 as of December 22, 2024 at a share price of $1.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Nuwellis Regains Compliance with Nasdaq Listing Requirements
GlobeNewswire Inc.
Dec 19, 2024 2:00 PM GMT
MINNEAPOLIS, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (the “Company” or “Nuwellis”) today announced that the Company received formal written notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained com
Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds
GlobeNewswire Inc.
Nov 05, 2024 2:28 PM GMT
MINNEAPOLIS, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company committed to transforming the lives of people with fluid overload, today announced the entry into
Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid
GlobeNewswire Inc.
Nov 04, 2024 1:30 PM GMT
Reimbursement rate to increase 397% per day effective January 1, 2025 New rate expected to encourage adoption of ultrafiltration therapy in the outpatient setting MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a comme